XENETIC BIOSCIENCES, INC. Operating Cash Flow
XENETIC BIOSCIENCES, INC. (XBIO) reported Operating Cash Flow of -$1.41 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$875.49K.
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$536.38K.
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$242.68K.
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$658.25K.
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$2.29M.
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$2.82M.
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$4.11M.
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$4.65M.
| Period end | Net Cash Provided by (Used in) Operating Activities 1 month | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 7 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 10 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 19 month | Net Cash Provided by (Used in) Operating Activities 22 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$875.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.41M 10-Q · filed 2026-08-06 | -$1.65M derived: sum of 3 quarters · filed 2026-08-06 | -$2.31M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2026-03-31 | -$536.38K 10-Q · filed 2026-05-12 | -$779.06K derived: sum of 2 quarters · filed 2026-05-12 | -$1.44M derived: sum of 3 quarters · filed 2026-05-12 | -$1.82M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-12-31 | -$242.68K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$900.93K derived: sum of 2 quarters · filed 2026-03-12 | -$1.28M derived: sum of 3 quarters · filed 2026-08-06 | -$2.29M 10-K · filed 2026-03-12 | |||||
| 2025-09-30 | -$658.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.04M derived: sum of 2 quarters · filed 2026-08-06 | -$2.04M 10-Q · filed 2025-11-12 | -$2.72M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-06-30 | -$383.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.39M 10-Q · filed 2026-08-06 | -$2.06M derived: sum of 3 quarters · filed 2026-08-06 | -$2.52M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-03-31 | -$1.00M 10-Q · filed 2026-05-12 | -$1.68M derived: sum of 2 quarters · filed 2026-05-12 | -$2.13M derived: sum of 3 quarters · filed 2026-05-12 | -$2.66M derived: sum of 4 quarters · filed 2026-05-12 | |||||
| 2024-12-31 | -$673.99K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.13M derived: sum of 2 quarters · filed 2026-03-12 | -$1.66M derived: sum of 3 quarters · filed 2026-03-12 | -$2.82M 10-K · filed 2026-03-12 | |||||
| 2024-09-30 | -$459.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$984.14K derived: sum of 2 quarters · filed 2025-11-12 | -$2.14M 10-Q · filed 2025-11-12 | -$2.94M derived: sum of 4 quarters · filed 2025-11-12 | |||||
| 2024-06-30 | -$525.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$1.68M 10-Q · filed 2025-08-12 | -$2.48M derived: sum of 3 quarters · filed 2025-08-12 | -$3.43M derived: sum of 4 quarters · filed 2025-08-12 | |||||
| 2024-03-31 | -$1.16M 10-Q · filed 2025-05-13 | -$1.95M derived: sum of 2 quarters · filed 2025-05-13 | -$2.90M derived: sum of 3 quarters · filed 2025-05-13 | -$4.17M derived: sum of 4 quarters · filed 2025-05-13 | |||||
| 2023-12-31 | -$793.03K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$1.74M derived: sum of 2 quarters · filed 2025-03-18 | -$3.01M derived: sum of 3 quarters · filed 2025-03-18 | -$4.11M 10-K · filed 2025-03-18 | |||||
| 2023-09-30 | -$949.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$2.22M derived: sum of 2 quarters · filed 2024-11-12 | -$3.32M 10-Q · filed 2024-11-12 | -$4.07M derived: sum of 4 quarters · filed 2024-11-12 | |||||
| 2023-06-30 | -$1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$2.37M 10-Q · filed 2024-08-13 | -$3.12M derived: sum of 3 quarters · filed 2024-08-13 | -$4.20M derived: sum of 4 quarters · filed 2024-08-13 | |||||
| 2023-03-31 | -$1.10M 10-Q · filed 2024-05-09 | -$1.85M derived: sum of 2 quarters · filed 2024-05-09 | -$2.93M derived: sum of 3 quarters · filed 2024-05-09 | -$3.66M derived: sum of 4 quarters · filed 2024-05-09 | |||||
| 2022-12-31 | -$750.91K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$1.83M derived: sum of 2 quarters · filed 2024-03-21 | -$2.56M derived: sum of 3 quarters · filed 2024-03-21 | -$4.65M 10-K · filed 2024-03-21 | |||||
| 2022-09-30 | -$1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$1.81M derived: sum of 2 quarters · filed 2023-11-09 | -$3.90M 10-Q · filed 2023-11-09 | -$5.35M derived: sum of 4 quarters · filed 2023-11-09 | |||||
| 2022-06-30 | -$728.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$2.82M 10-Q · filed 2023-08-10 | -$4.28M derived: sum of 3 quarters · filed 2023-08-10 | -$5.31M derived: sum of 4 quarters · filed 2023-08-10 | |||||
| 2022-03-31 | -$2.09M 10-Q · filed 2023-05-11 | -$3.55M derived: sum of 2 quarters · filed 2023-05-11 | -$4.58M derived: sum of 3 quarters · filed 2023-05-11 | -$5.31M derived: sum of 4 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | -$1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$2.49M derived: sum of 2 quarters · filed 2023-03-22 | -$3.22M derived: sum of 3 quarters · filed 2023-03-22 | -$4.74M 10-K · filed 2023-03-22 | |||||
| 2021-09-30 | -$1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$1.76M derived: sum of 2 quarters · filed 2022-11-09 | -$3.28M 10-Q · filed 2022-11-09 | -$4.23M derived: sum of 4 quarters · filed 2022-11-09 | |||||
| 2021-06-30 | -$726.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$2.25M 10-Q · filed 2022-08-11 | -$3.20M derived: sum of 3 quarters · filed 2022-08-11 | -$4.21M derived: sum of 4 quarters · filed 2022-08-11 | |||||
| 2021-03-31 | -$1.52M 10-Q · filed 2022-05-12 | -$2.47M derived: sum of 2 quarters · filed 2022-05-12 | -$3.48M derived: sum of 3 quarters · filed 2022-05-12 | -$4.79M derived: sum of 4 quarters · filed 2022-05-12 | |||||
| 2020-12-31 | -$953.66K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$1.97M derived: sum of 2 quarters · filed 2022-03-22 | -$3.27M derived: sum of 3 quarters · filed 2022-03-22 | -$4.27M 10-K · filed 2022-03-22 | |||||
| 2020-09-30 | -$1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$2.31M derived: sum of 2 quarters · filed 2021-11-12 | -$3.31M 10-Q · filed 2021-11-12 | -$4.99M derived: sum of 4 quarters · filed 2021-11-12 | |||||
| 2020-06-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$2.30M 10-Q · filed 2021-08-12 | -$3.98M derived: sum of 3 quarters · filed 2021-08-12 | -$6.40M derived: sum of 4 quarters · filed 2021-08-12 | |||||
| 2020-03-31 | -$1.00M 10-Q · filed 2021-05-11 | -$2.68M derived: sum of 2 quarters · filed 2021-05-11 | -$5.09M derived: sum of 3 quarters · filed 2021-05-11 | -$6.15M derived: sum of 4 quarters · filed 2021-05-11 | |||||
| 2019-12-31 | -$1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$4.09M derived: sum of 2 quarters · filed 2021-03-16 | -$5.14M derived: sum of 3 quarters · filed 2021-03-16 | -$6.40M 10-K · filed 2021-03-16 | |||||
| 2019-09-30 | -$2.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$3.47M derived: sum of 2 quarters · filed 2020-11-12 | -$4.72M 10-Q · filed 2020-11-12 | -$5.76M derived: sum of 4 quarters · filed 2020-11-12 | |||||
| 2019-06-30 | -$1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$2.31M 10-Q · filed 2020-08-12 | -$3.35M derived: sum of 3 quarters · filed 2020-08-12 | -$5.01M derived: sum of 4 quarters · filed 2020-08-12 | |||||
| 2019-03-31 | -$1.25M 10-Q · filed 2020-05-14 | -$2.30M derived: sum of 2 quarters · filed 2020-05-14 | -$3.96M derived: sum of 3 quarters · filed 2020-05-14 | -$6.05M derived: sum of 4 quarters · filed 2020-05-14 | |||||
| 2018-12-31 | -$1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$2.71M derived: sum of 2 quarters · filed 2020-03-26 | -$4.80M derived: sum of 3 quarters · filed 2020-03-26 | -$6.46M 10-K · filed 2020-03-26 | |||||
| 2018-09-30 | -$1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$3.76M derived: sum of 2 quarters · filed 2019-11-14 | -$5.42M 10-Q · filed 2019-11-14 | -$584.77K derived: sum of 4 quarters · filed 2019-11-14 | |||||
| 2018-06-30 | -$2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$3.75M 10-Q · filed 2019-08-14 | $1.08M derived: sum of 3 quarters · filed 2019-08-14 | -$553.83K derived: sum of 4 quarters · filed 2019-08-14 | |||||
| 2018-03-31 | -$1.67M 10-Q · filed 2019-05-13 | $3.17M derived: sum of 2 quarters · filed 2019-05-13 | $1.53M derived: sum of 3 quarters · filed 2019-05-13 | -$453.42K derived: sum of 4 quarters · filed 2019-05-13 | |||||
| 2017-12-31 | $4.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $3.20M derived: sum of 2 quarters · filed 2019-03-29 | $1.21M derived: sum of 3 quarters · filed 2019-03-29 | $1.49M 10-K · filed 2019-03-29 | |||||
| 2017-09-30 | -$1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$3.62M derived: sum of 2 quarters · filed 2018-11-09 | -$3.34M 10-Q · filed 2018-11-09 | -$7.97M derived: sum of 4 quarters · filed 2018-11-09 | |||||
| 2017-06-30 | -$1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | -$1.71M 10-Q · filed 2018-08-10 | -$6.33M derived: sum of 3 quarters · filed 2018-08-10 | ||||||
| 2017-03-31 | $280.81K 10-Q · filed 2018-05-15 | -$4.34M derived: sum of 2 quarters · filed 2018-05-15 | |||||||
| 2016-12-31 | -$4.62M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | -$8.79M 10-K · filed 2018-03-30 | |||||||
| 2016-09-30 | -$4.16M 10-Q · filed 2017-11-14 | ||||||||
| 2013-12-31 | -$6.05M 10-K · filed 2015-07-20 | ||||||||
| 2013-11-30 | -$173.14K 10-Q · filed 2014-01-10 | $77.29K derived: sum of 2 quarters · filed 2014-01-10 | $94.49K derived: sum of 3 quarters · filed 2014-01-10 | ||||||
| 2013-08-31 | $250.43K derived: 10-K 12 month − 10-Q 9 month · filed 2013-11-27 | $267.64K derived: sum of 2 quarters · filed 2013-11-27 | $280.61K 10-K · filed 2013-11-27 | ||||||
| 2013-05-31 | $17.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-07-17 | $30.18K 10-Q · filed 2013-07-17 | $16.87K 10-Q · filed 2013-07-17 | ||||||
| 2013-02-28 | $12.97K 10-Q · filed 2013-04-22 | -$336.00 10-Q · filed 2013-04-22 | |||||||
| 2012-12-31 | -$6.26M 10-K · filed 2015-07-20 | ||||||||
| 2012-08-31 | -$1.05K derived: 10-K 12 month − 10-Q 9 month · filed 2013-11-27 | -$14.35K derived: sum of 2 quarters · filed 2013-11-27 | -$11.17K derived: sum of 3 quarters · filed 2013-11-27 | -$12.99K 10-K · filed 2013-11-27 | |||||
| 2012-05-31 | -$13.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-07-17 | -$10.12K derived: sum of 2 quarters · filed 2013-07-17 | -$11.94K 10-Q · filed 2013-07-17 | -$12.26K 10-Q · filed 2012-07-16 | |||||
| 2012-02-29 | $3.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-04-22 | $1.35K 10-Q · filed 2013-04-22 | $1.04K 10-Q · filed 2012-04-24 | ||||||
| 2011-11-30 | -$1.82K 10-Q · filed 2013-01-22 | ||||||||
| 2011-08-31 | -$313.00 10-K · filed 2012-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |